Phase I study of concurrent weekly docetaxel, high-dose intensity-modulated radiation therapy (IMRT) and androgen-deprivation therapy (ADT) for high-risk prostate cancer
2012 ◽
Vol 110
(11b)
◽
pp. E721-E726
◽
2013 ◽
Vol 87
(2)
◽
pp. S374-S375
2010 ◽
Vol 78
(3)
◽
pp. S126
2003 ◽
Vol 21
(4)
◽
pp. 306-307
◽
2004 ◽
Vol 60
(1)
◽
pp. S446-S447
2004 ◽
Vol 60
◽
pp. S446-S447
2014 ◽
Vol 90
(1)
◽
pp. S418-S419
2009 ◽
Vol 91
(2)
◽
pp. 237-242
◽